Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues.

The amyloid precursor protein (APP) is a type I transmembrane glycoprotein widely studied for its role as the source of β-amyloid peptide, accumulation of which is causal in at least some cases of Alzheimer's disease (AD). APP is expressed ubiquitously and is involved in diverse biological processes. Growing bodies of evidence indicate connections between AD and somatic metabolic disorders related to type 2 diabetes, and App-/- mice show alterations in glycemic regulation. We find that App-/- mice have higher levels of insulin-degrading enzyme (IDE) mRNA, protein, and activity compared with wild-type controls. This regulation of IDE by APP was widespread across numerous tissues, including liver, skeletal muscle, and brain as well as cell types within neural tissue, including neurons, astrocytes, and microglia. RNA interference-mediated knockdown of APP in the SIM-A9 microglia cell line elevated IDE levels. Fasting levels of blood insulin were lower in App-/- than App+/+ mice, but the former showed a larger increase in response to glucose. These low basal levels may enhance peripheral insulin sensitivity, as App-/- mice failed to develop impairment of glucose tolerance on a high-fat, high-sucrose ("Western") diet. Insulin levels and insulin signaling were also lower in the App-/- brain; synaptosomes prepared from App-/- hippocampus showed diminished insulin receptor phosphorylation compared with App+/+ mice when stimulated ex vivo. These findings represent a new molecular link connecting APP to metabolic homeostasis and demonstrate a novel role for APP as an upstream regulator of IDE in vivo.

• Publication year

  2019

• Venue

  American Journal of Physiology. Endocrinology and Metabolism

• Publication date

  2019-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1152/ajpendo.00279.2018PMID 30422705PMCID PMC6417684
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• APP deficiency results in resistance to obesity but impairs glucose tolerance upon high fat feeding.

  2018influential reference
• Insulin transport into the brain.

  2018cited by this paper
• Insulin-Degrading Enzyme in the Fight against Alzheimer's Disease.

  2018cited by this paper
• Lifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer’s Disease

  2018cited by this paper
• Association between diabetes and causes of dementia: Evidence from a clinicopathological study

  2017cited by this paper
• Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities

  2017cited by this paper
• Impaired peripheral glucose homeostasis and Alzheimer's disease

  2017cited by this paper
• Diabetes and Aging: Unique Considerations and Goals of Care

  2017cited by this paper
• Intranasal insulin in Alzheimer’s disease: Food for thought

  2017cited by this paper
• Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline

  2017cited by this paper
• The conformational epitope for a new Aβ42 protofibril‐selective antibody partially overlaps with the peptide N‐terminal region

  2017cited by this paper
• Amyloid precursor protein in pancreatic islets.

  2017cited by this paper
• Amyloid precursor protein modulates macrophage phenotype and diet-dependent weight gain

  2017cited by this paper
• Interleukin-6 increases the expression and activity of insulin-degrading enzyme

  2017cited by this paper
• Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome

  2017cited by this paper
• Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer’s disease: metabolic basis for dementia

  2016cited by this paper
• Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease

  2016cited by this paper
• The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.

  2016cited by this paper
• The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients

  2016cited by this paper
• Insulin Regulates Astrocytic Glucose Handling Through Cooperation With IGF-I

  2016cited by this paper
• The amyloid hypothesis of Alzheimer's disease at 25 years

  2016cited by this paper
• Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer’s disease mouse model

  2016cited by this paper
• Aerobic Glycolysis in the Frontal Cortex Correlates with Memory Performance in Wild-Type Mice But Not the APP/PS1 Mouse Model of Cerebral Amyloidosis

  2016cited by this paper
• An improved approach to align and embed multiple brain samples in a gelatin-based matrix for simultaneous histological processing.

  2016cited by this paper
• A method to determine insulin responsiveness in synaptosomes isolated from frozen brain tissue.

  2016cited by this paper
• Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.

  2016cited by this paper
• Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability.

  2016cited by this paper
• Insulin signalling in Alzheimer′s disease and diabetes: from epidemiology to molecular links

  2016cited by this paper
• APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease

  2016cited by this paper
• Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation

  2015cited by this paper
• Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo.

  2015cited by this paper
• Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice

  2015cited by this paper
• A novel cell line from spontaneously immortalized murine microglia.

  2014cited by this paper
• An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex

  2014cited by this paper
• Diabetes and Elevated Hemoglobin A1c Levels Are Associated with Brain Hypometabolism but Not Amyloid Accumulation

  2014cited by this paper
• Cycle on Wheels: Is APP Key to the AppBp1 Pathway?

  2014influential reference
• Altered amyloid precursor protein processing regulates glucose uptake and oxidation in cultured rodent myotubes

  2014cited by this paper
• Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones

  2014cited by this paper
• Insulin Action in Brain Regulates Systemic Metabolism and Brain Function

  2014cited by this paper
• Origins of amyloid-β

  2013cited by this paper
• Physiological functions of APP family proteins.

  2012cited by this paper
• Isolation and culture of rat embryonic neural cells: a quick protocol.

  2012cited by this paper
• Amyloid Precursor Protein and Proinflammatory Changes Are Regulated in Brain and Adipose Tissue in a Murine Model of High Fat Diet-Induced Obesity

  2012cited by this paper
• Integrative Analysis of a Cross-Loci Regulation Network Identifies App as a Gene Regulating Insulin Secretion from Pancreatic Islets

  2012cited by this paper
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

  2012cited by this paper
• Amyloid precursor protein (APP) regulates synaptic structure and function.

  2012cited by this paper
• Are amyloid‐degrading enzymes viable therapeutic targets in Alzheimer’s disease?

  2012cited by this paper
• Beta amyloid-independent role of amyloid precursor protein in generation and maintenance of dendritic spines.

  2010cited by this paper
• Improved Synthesis of ADAM10 Inhibitor GI254023X

  2010cited by this paper
• Irs1 serine 307 promotes insulin sensitivity in mice.

  2010cited by this paper
• Increased food intake leads to obesity and insulin resistance in the tg2576 Alzheimer's disease mouse model.

  2010cited by this paper
• Plasma Amyloid-β Peptide Levels Correlate with Adipocyte Amyloid Precursor Protein Gene Expression in Obese Individuals

  2009cited by this paper
• Amyloid precursor protein and its homologues: a family of proteolysis-dependent receptors

  2009cited by this paper
• Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

  2009cited by this paper
• Metabolic Syndrome and Risk for Incident Alzheimer's Disease or Vascular Dementia

  2009cited by this paper
• Faculty Opinions recommendation of A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference.

  2008cited by this paper
• Muscle-Specific IRS-1 Ser→Ala Transgenic Mice Are Protected From Fat-Induced Insulin Resistance in Skeletal Muscle

  2008cited by this paper
• Identification of the Alzheimer's disease amyloid precursor protein (APP) and its homologue APLP2 as essential modulators of glucose and insulin homeostasis and growth

  2008cited by this paper
• Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues.

  2008cited by this paper
• Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin beta1

  2008cited by this paper
• Amyloid Precursor Protein Expression Is Upregulated in Adipocytes in Obesity

  2008cited by this paper
• A Critical Function for β-Amyloid Precursor Protein in Neuronal Migration Revealed by In Utero RNA Interference

  2007cited by this paper
• Tumor necrosis factor alpha stimulates NMDA receptor activity in mouse cortical neurons resulting in ERK‐dependent death

  2007cited by this paper
• Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease.

  2006cited by this paper
• Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism

  2006cited by this paper
• Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.

  2005cited by this paper
• Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

  2005cited by this paper
• Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules.

  2005cited by this paper
• A {gamma}-secretase-independent mechanism of signal transduction by the amyloid precursor protein.

  2005cited by this paper
• A γ-Secretase-independent Mechanism of Signal Transduction by the Amyloid Precursor Protein*

  2005cited by this paper
• β-Amyloid-Stimulated Microglia Induce Neuron Death via Synergistic Stimulation of Tumor Necrosis Factor α and NMDA Receptors

  2005cited by this paper
• The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

  2003cited by this paper
• Diabetes Mellitus Is a Risk Factor for Vascular Dementia, but Not for Alzheimer's Disease: A Population-Based Study of the Oldest Old

  2002cited by this paper
• Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.

  2002cited by this paper
• A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60

  2001cited by this paper
• A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60.

  2001cited by this paper
• The Intracellular Domain of the β-Amyloid Precursor Protein Is Stabilized by Fe65 and Translocates to the Nucleus in a Notch-like Manner*

  2001cited by this paper
• Mice with Combined Gene Knock-Outs Reveal Essential and Partially Redundant Functions of Amyloid Precursor Protein Family Members

  2000cited by this paper
• Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain

  2000cited by this paper
• Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells

  1999cited by this paper
• No hippocampal neuron or synaptic bouton loss in learning-impaired aged beta-amyloid precursor protein-null mice.

  1999cited by this paper
• Insulin degradation: progress and potential.

  1998cited by this paper
• Mechanism of activation of protein kinase B by insulin and IGF‐1.

  1996cited by this paper
• Inhibitory action of amyloid precursor protein against human Hageman factor (factor XII).

  1995cited by this paper
• Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene.

  1994cited by this paper
• The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily.

  1994cited by this paper
• Optimized survival of hippocampal neurons in B27‐supplemented neurobasal™, a new serum‐free medium combination

  1993cited by this paper
• The predominant form of the amyloid beta-protein precursor in human brain is protease nexin 2.

  1991cited by this paper
• Abnormalities of Glucose Metabolism in Alzheimer's Disease

  1991cited by this paper
• Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues.

  1988cited by this paper
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

  1984cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Type 2 Diabetes and Alzheimer’s Disease: Molecular Mechanisms and Therapeutic Insights with a Focus on Anthocyanin

  2026cites this paper
• The effects of Honokiol on the liver of Alzheimer's disease mice by upregulating SIRT3

  2025cites this paper
• Insulin-degrading enzyme confers neuroprotection in Parkinson’s disease by inhibiting the Hippo signaling pathway

  2025cites this paper
• Emerging Plant-Based Nanotechnological Advances and Molecular Insights for Type‑2 Diabetes, Diagnosis and Treatments-Recent Trends and Future Prospects

  2025cites this paper
• Integrative analysis of DEGs and regulatory networks in T2DM: identification of core genes and regulatory elements as novel therapeutic targets

  2025cites this paper
• Les dépôts amyloïdes dans les îlots de Langerhans, fonctions pathologiques et cibles thérapeutiques

  2024cites this paper
• Does Metabolic Manager Show Encouraging Outcomes in Alzheimer's?: Challenges and Opportunity for Protein Tyrosine Phosphatase 1b Inhibitors

  2024cites this paper
• Diabetes mellitus and Alzheimer's disease: Vacuolar adenosine triphosphatase as a potential link

  2024cites this paper
• Experimental approaches for altering the expression of Abeta‐degrading enzymes

  2023cites this paper
• DNA methylation of insulin signaling pathways is associated with HOMA2-IR in primary myoblasts from older adults

  2023cites this paper
• Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging

  2023cites this paper
• The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD

  2023cites this paper
• Effect of insulin and cinnamon extract on spatial memory and gene expression of GLUT1, 3, and 4 in streptozotocin-induced Alzheimer’s model in rats

  2023cites this paper
• Humulus lupulus L. Extract Protects against Senior Osteoporosis through Inhibiting Amyloid β Deposition and Oxidative Stress in APP/PS1 Mutated Transgenic Mice and Osteoblasts

  2023cites this paper
• Amelioration of Age-Related Multiple Neuronal Impairments and Inflammation in High-Fat Diet-Fed Rats: The Prospective Multitargets of Geraniol

  2022cites this paper
• Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes

  2022cites this paper
• Amyloid β-Peptide Effects on Glucose Regulation Are Dependent on Apolipoprotein E Genotype

  2022cites this paper
• Reduced insulin sensitivity and increased β/α cell mass is associated with reduced hepatic insulin-degrading enzyme activity in pregnant rats.

  2021cites this paper
• Role of liraglutide in Alzheimer’s disease pathology

  2021influential citation
• Alzheimer amyloid-β- peptide disrupts membrane localization of glucose transporter 1 in astrocytes: implications for glucose levels in brain and blood

  2020cites this paper
• Comparing prophylactic effect of exercise and metformin on cognitive brain functions in rats with type 3 diabetes mellitus

  2020cites this paper
• Expression of IDE and PITRM1 genes in ERN1 knockdown U87 glioma cells: effect of hypoxia and glucose deprivation

  2020influential citation
• Weight Loss is a Preclinical Signal of Cerebral Amyloid Deposition and Could Predict Cognitive Impairment in Elderly Adults

  2020cites this paper
• Synaptosome as a tool in Alzheimer's disease research.

  2020cites this paper
• Association of plasma β-amyloid 40 and 42 concentration with type 2 diabetes among Chinese adults

  2020cites this paper
• Neurodegeneration in type 2 diabetes: Alzheimer's as a case study

  2020cites this paper
• Molecular prospect of type-2 diabetes: Nanotechnology based diagnostics and therapeutic intervention

  2020cites this paper
• Current and Emerging Pharmacological Targets for the Treatment of Alzheimer’s Disease

  2019cites this paper
• The Precursor to Glutathione (GSH), γ-Glutamylcysteine (GGC), Can Ameliorate Oxidative Damage and Neuroinflammation Induced by Aβ40 Oligomers in Human Astrocytes

  2019cites this paper
• Insulin transport into the brain.

  2018cites this paper
• Association between diabetes and causes of dementia: Evidence from a clinicopathological study

  2017cites this paper
• Negative correlation between microRNA and insulin sensitivity gene expression in adipose tissue: potential implications for diabetes and neurodegenerative diseases

  year unknowncites this paper